You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mTOR inhibitor

Showing 1 - 25 of 7,813
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Pulmonary Hypertension Trial in United States (ABI-009, nab-rapamycin, albumin-bound rapamycin)

Active, not recruiting
  • Pulmonary Hypertension
  • ABI-009, nab-rapamycin, albumin-bound rapamycin
  • Tucson, Arizona
  • +5 more
Aug 22, 2022

Metastatic Breast Cancer Trial in France (Biopsy)

Completed
  • Metastatic Breast Cancer
  • Biopsy
  • Angers, France
  • +11 more
Sep 19, 2022

Desmoid Tumor Trial in United States (Sirolimus)

Completed
  • Desmoid Tumor
  • Los Angeles, California
  • +7 more
Jul 5, 2022

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 13, 2023

Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

Recruiting
  • Triple-negative Breast Cancer
  • Pyrotinib with Capecitabine
  • +6 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 8, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

HNSCC Trial in Houston (Bimiralisib)

Terminated
Has Results
  • HNSCC
  • Houston, Texas
    M.D. Anderson Cancer Center
Dec 22, 2021

Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

Recruiting
  • Angiofibroma of Face
  • Tuberous Sclerosis
  • Sirolimus 0.2%
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 2, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

Active, not recruiting
  • Glioblastoma, Adult
  • Paxalisib (GDC-0084)
  • Los Angeles, California
  • +5 more
Aug 16, 2022

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2021

Advanced Cancers Trial in Houston (other, drug, behavioral)

Terminated
  • Advanced Cancers
  • Placebo
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 4, 2021

Everolimus Related Pneumonitis in MBC

Completed
  • Everolimus
  • Pneumonitis
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 16, 2020

    Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Los Angeles, California
    • +1 more
    Jan 25, 2022

    Advanced or Metastatic Pancreatic Adenocarcinoma Trial in Germany (everolimus)

    Completed
    • Advanced or Metastatic Pancreatic Adenocarcinoma
    • Halle, Germany
    • +4 more
    Dec 17, 2020

    Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

    Completed
    • Advanced Malignant Neoplasm
    • +3 more
    • Anakinra
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 24, 2021

    Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

    Completed
    Has Results
    • Multiple Myeloma
    • +6 more
    • Los Angeles, California
    • +15 more
    Dec 9, 2022

    Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)

    Completed
    • Advanced Cancer
    • Solid Tumor
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jun 1, 2020